摘要
Background: Human platelets (PLT) and PLT-extracellular vesicles (PEV) released upon thrombin activation express receptors that interact with tumour cells and, thus, can serve as a delivery platform of anti-cancer agents. Drug-loaded nanoparticles coated with PLT membranes were demonstrated to have improved targeting efficiency to tumours, but remain impractical for clinical translation. PLT and PEV targeted drug delivery vehicles should facilitate clinical developments if clinical-grade procedures can be developed. Methods: PLT from therapeutic-grade PLT concentrate (PC; N > 50) were loaded with doxorubicin (DOX) and stored at - 80 °C (DOX-loaded PLT) with 6% dimethyl sulfoxide (cryopreserved DOX-loaded PLT). Surface markers and function of cryopreserved DOX-loaded PLT was confirmed by Western blot and thromboelastography, respectively. The morphology of fresh and cryopreserved naïve and DOX-loaded PLT was observed by scanning electron microscopy. The content of tissue factor-expressing cancer-derived extracellular vesicles (TF-EV) present in conditioned medium (CM) of breast cancer cells cultures was measured. The drug release by fresh and cryopreserved DOX-loaded PLT triggered by various pH and CM was determined by high performance liquid chromatography. The thrombin activated PEV was analyzed by nanoparticle tracking analysis. The cellular uptake of DOX from PLT was observed by deconvolution microscopy. The cytotoxicities of DOX-loaded PLT, cryopreserved DOX-loaded PLT, DOX and liposomal DOX on breast, lung and colon cancer cells were analyzed by CCK-8 assay. Results: 15~36 × 106 molecules of DOX could be loaded in each PLT within 3 to 9 days after collection. The characterization and bioreactivity of cryopreserved DOX-loaded PLT were preserved, as evidenced by (a) microscopic observations, (b) preservation of important PLT membrane markers CD41, CD61, protease activated receptor-1, (c) functional activity, (d) reactivity to TF-EV, and (e) efficient generation of PEV upon thrombin activation. The transfer of DOX from cryopreserved PLT to cancer cells was achieved within 90 min, and stimulated by TF-EV and low pH. The cryopreserved DOX-loaded PLT formulation was 7~23-times more toxic to three cancer cells than liposomal DOX. Conclusions: Cryopreserved DOX-loaded PLT can be prepared under clinically compliant conditions preserving the membrane functionality for anti-cancer therapy. These findings open perspectives for translational applications of PLT-based drug delivery systems.
原文 | 英語 |
---|---|
文章編號 | 45 |
頁(從 - 到) | 45 |
期刊 | Journal of Biomedical Science |
卷 | 27 |
發行號 | 1 |
DOIs | |
出版狀態 | 已發佈 - 3月 23 2020 |
ASJC Scopus subject areas
- 內分泌學、糖尿病和代謝
- 分子生物學
- 臨床生物化學
- 細胞生物學
- 生物化學(醫學)
- 藥學(醫學)
指紋
深入研究「Clinical-grade cryopreserved doxorubicin-loaded platelets: Role of cancer cells and platelet extracellular vesicles activation loop」主題。共同形成了獨特的指紋。資料集
-
Additional file 3 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y.-W. (Creator), Huang, C.-C. (Contributor), Changou, C. A. (Creator), Lu, L.-S. (Creator), Goubran, H. (Creator) & Burnouf, T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017385.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017385/1
資料集: Dataset
-
Additional file 2 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y.-W. (Creator), Huang, C.-C. (Contributor), Changou, C. A. (Creator), Lu, L.-S. (Creator), Goubran, H. (Creator) & Burnouf, T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017382.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017382/1
資料集: Dataset
-
Additional file 5 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y.-W. (Creator), Huang, C.-C. (Contributor), Changou, C. A. (Creator), Lu, L.-S. (Creator), Goubran, H. (Creator) & Burnouf, T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017391.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017391/1
資料集: Dataset